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Abstract: In late October 2011, the Monroe County Department of Public Health 
(MCDPH) was notified of a suspected case of meningitis in a 9-year old girl from Monroe 
County, NY. Laboratory testing at the New York State Department of Health (NYSDOH) 
Wadsworth Center confirmed the identification of Haemophilus influenzae serotype e (Hie) 
isolated from the patient’s cerebrospinal fluid (CSF) using real-time polymerase chain 
reaction (RT-PCR). The universal immunization of infants with conjugate H. influenzae 
type b (Hib) vaccine has significantly reduced the incidence of invasive Hib disease, including 
meningitis, one of the most serious complications for infected children. Not surprisingly, as 
the epidemiology of invasive H. influenzae continues to change, non-Hib serotypes will 
likely become more common. The findings reported here underscore the importance for 
clinicians, public health officials, and laboratory staff to consider non-Hib pathogens in 
pediatric cases of meningitis, especially when initial investigations are inconclusive. 
OPEN ACCESS 
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1. Introduction 
During the pre-Haemophilus influenzae serotype b (Hib) conjugate vaccine era, Hib was the cause 
of more than 95% of invasive H. influenzae disease among younger children [1]. Further, meningitis 
occurred in about two-thirds of these children with invasive Hib disease, with 15%–30% of survivors 
having serious neurological sequelae such as hearing impairment, mental retardation, seizure disorder, 
cognitive and developmental delay, and paralysis.  
The Center for Disease Control and Prevention Emerging Infection Program’s Active Bacterial 
Core Surveillance (ABCs) system suggests that Hib currently accounts for a rate of 0.20/100,000 cases 
among children <5 years based on provisional 2012 data [2]. The universal recommendation for the 
immunization of infants in the United States beginning at two months of age with conjugate H. influenzae 
type b (Hib) vaccine began in 1991 [3]. This has significantly reduced the incidence of invasive Hib 
disease, including meningitis, one of the most serious complications for infected children. As the 
epidemiology of invasive H. influenzae continues to change, non-Hib serotypes such as Haemophilus 
influenzae serotype e (Hie) are increasing. We present the case of a patient who was clinically 
diagnosed with bacterial meningitis but all routine laboratory cultures showed no growth at the local 
lab. We then discuss the importance of public health involvement when a bacterial meningitis case is 
identified but etiology of the organism is unknown.  
2. Case Report 
On October 24, 2011 (Day #1), a previously healthy 9-year old girl with a 2-week history of upper 
respiratory tract infection symptoms, including a nonproductive cough and negative strep throat 
culture, presented to a pediatric office with fever (Tmax of 103 degrees F), headache, stiff neck, 
irritability, and no rash. She was presumptively diagnosed with bacterial meningitis and given a single 
dose of intramuscular ceftriaxone (50 mg/kg) before being transferred to a local emergency department. 
At the hospital, cerebrospinal fluid (CSF) obtained through lumbar puncture revealed a cloudy appearance, 
with a white blood cell (WBC) count of 2,942/mm
3
 (polys 88%), glucose of 5 mg/dL, and protein of 
196 mg/dL; gram stain initially showed no organisms except, on cytospin, four gram-negative bacilli 
(not coccobacilli) were noted; cultures were negative. A head computed tomography (CT) scan with 
contrast suggested acute on chronic pansinusitis; subsequent magnetic resonance imaging (MRI) of the 
brain with contrast also demonstrated pansinusitis with no evidence of intracranial abscess or tracking 
from the sinuses. The patient was started on intravenous ceftriaxone, gentamycin, and vancomycin; no 
steroids were administered, given the unclear gram stain results and low suspicion for Hib meningitis. 
The patient was transferred to the pediatric intensive care unit (PICU). Since meningococcal disease 
could not be ruled out, the local health department was contacted to initiate an investigation. The 
patient significantly improved and was transferred from the PICU to a regular pediatric floor on 
October 26 (Day #3); at that time, her antibiotic regimen was switched to ceftriaxone alone as the 
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initial negative CSF culture following only a single dose of ceftriaxone suggested that the organism 
was susceptible to that antibiotic. On October 30 (Day #7), she was discharged to home. On follow up 
with her pediatrician on November 2 (Day #10), she reported some mild headaches and fatigue but, 
otherwise, had no neurological deficits and was doing well. She completed a 14-day course of ceftriaxone. 
On October 26, 2011 (Day #3), Monroe County Department of Public Health (MCDPH) staff 
interviewed the patient’s mother to determine potential exposure and need for post exposure 
prophylaxis (PEP) for bacterial meningitis due to invasive H. influenzae and/or meningococcal disease. 
The patient’s family received prescriptions for PEP: ciprofloxacin for the parents and rifampin for the 
younger sibling. The New York State Immunization Information System (NYSIIS) confirmed that the 
patient and the younger sibling were up to date in their immunizations, including the Hib conjugate 
vaccine (with doses given at 2, 4, 6 and 15 months old). On October 27, 2011 (Day #4), laboratory 
testing at the New York State Department of Health Wadsworth Center identified Hie from the 
patient’s CSF using RT-PCR. No further action was taken by MCDPH staff regarding potential PEP. 
3. Conclusions 
In the post-Hib conjugated vaccine era, Waggoner-Fountain et al. first reported on four cases of 
non-type b encapsulated H. influenzae meningitis diagnosed in children here in the United States (two 
due to Hie and two due to H. influenzae type f [Hif]) [4]. Among these cases, only one child was 
school-aged: a 6-year old boy. Despite his age, he had only received a single dose of Hib conjugated 
vaccine at 15 months old. The boy’s CSF revealed a WBC count of 3,440/mm3, glucose of 34 mg/dL, 
and protein of 80 mg/dL. Laboratory testing identified Hie in his blood and CSF; he was treated with 
ceftriaxone for ten days and fully recovered.  
For the post-Hib conjugated vaccine era, we are not aware of any other published cases of 
meningitis due to Hie among previously healthy school-aged children here in the U.S.; however, 
Ladhani et al. reported Hie meningitis amongst two previously healthy children in England and Wales [5]. 
The identification of Hie is likely influenced by the serotyping method used, as Satola et al. have 
shown that PCR is the gold standard for capsule typing [6]. Indeed, slide agglutination serotyping 
(SAST) may be unreliable and, in particular, may overestimate the frequency of H. influenzae type a 
(Hia). This finding may account for the relatively high percentage of Hia noted among children with 
invasive disease in one study [7].  
As surveillance for H. influenzae has improved during the post-Hib conjugate vaccine era, including 
referral of isolates for serotyping and wider use of PCR, research has shown that serotype e is 
increasing [5,8]. This case report underscores the importance of using real-time PCR as a rapid and 
accurate test to diagnose acute bacterial meningitis when cultures are negative. The changing epidemiology 
of invasive H. influenzae disease underscores the success of the Hib conjugate vaccine; it also suggests 
there might be a need to develop vaccines that cover other serotypes in the future. 
For invasive H. influenzae, current guidelines specify chemoprophylaxis with a four-day course of 
rifampin for household contacts of cases involving Hib but no other serotypes [9]. At this time, it is not 
clear what the efficacy is for chemoprophylaxis in non-b typeable disease, such as Hie [10]. 
Indeed, knowing the risk of secondary transmission from invasive non-Hib index cases will require 
more data from continued surveillance efforts.  
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